Fox Business - The Power to Prosper
Search Site

Jeff Kindler

Bullying: Deal With It

Some say workplace bullying is a huge problem that's just beginning to get the attention it deserves. Others think it's just another overused excuse for whiny, entitled, thin-skinned employees who can't handle a little friction to get out of work.Personally, I've seen it both ways and every which way in between. When it comes to how people treat each other at work, there's quite a spectrum of obnoxious, disruptive behavior. Besides, we all have one thing in common. We all have issues. And like it or not, we bring our emotional baggage with us wherever we go – including the office.That's what makes the Petrie dish of drama and dysfunction we call the workplace so fascinating and entertaining. That is, when it isn't turning our own lives into a living hell.What's come to be known as workplace bullying has been around since telephones and typewriters. While it is annoying and messy to deal with, it isn't rocket science. And it only mushrooms into disaster under three conditions: when it's...

Read More

  1. Obama's Search for Commerce Secretary Could Snag Google's Schmidt

    To fill a new void at the top of the Commerce Department , the White House is reportedly thinking about tapping Google (NASDAQ:GOOG) CEO Eric Schmidt or former Pfize...

  2. Outgoing Pfizer CEO to Get $9.6M in Pay

    FBN's Connell McShane on the compensation package Pfizer CEO Jeff Kindler will receive.

  3. Politics Behind Pfizer CEO Quitting

    National Legal & Policy Center President Pete Flaherty on the political dimensions behind Jeff Kindler stepping down as CEO of Pfizer.

  4. Lifeless Markets End in Holding Pattern

    FOX Business: The Power to ProsperAfter bouncing between minor gains and losses throughout the day, Wall Street landed on the fence on Monday, preserving virtually a...

  5. Futures Fall as Stocks Track Euro, Commodities

    FOX Business: The Power to ProsperStock futures pointed to modest declines early Monday as U.S. traders, armed with little economic data or company news of their own...

  6. Pfizer's Kindler Retires, Read Named CEO

    FBN's Sandra Smith on Pfizer CEO Jeff Kindler announcing his retirement after four and a half years.

  7. Pfizer's CEO Unexpectedly Resigns

    Pfizer 's President and CEO Jeffrey Kindler unexpectedly resigned his post, the company said in a statement late Sunday, ending his 4-1/2 year tenure as head of the ...

  8. Pfizer Posts Higher-Than-Expected Profit and Sales

    Helped by its $67 billion mega merger with Wyeth, Pfizer (NYSE:PFE) reported second-quarter results on Tuesday that solidly beat Wall Street’s expectations and issue...

  9. Pfizer and Wyeth CEOs on $68B DEAL

    Pfizer and Wyeth CEOs

  10. Pfizer CEO on Economy, Pharmaceuticals

    Jeff Kindler talks about pharmaceuticals

  11. PFIZER CHAIRMAN AND CEO TO FBN: PASS THE BAILOUT PLAN NOW

    September 23, 2008 05:31 PM UTC by Liz ClamanPFIZER CHAIRMAN AND CEO TO FBN: PASS THE BAILOUT PLAN NOWGang,Jeff Kindler, Chairman and CEO of Pfizer (PFE) joined me e...

  1. Why We Have to Hold Leaders Accountable

    Jeff Kindler was a rising star in the legal world. After getting a Harvard law degree he worked at the FCC, clerked for a Supreme Court judge, and made partner at a ...

  2. Former Pfizer Chairman Kindler Joins Venture-Capital Firm Lux

    Former Pfizer Inc. (PFE) Chairman and Chief Executive Jeff Kindler has joined venture-capital firm Lux Capital, to help work with the firm's portfolio companies and ...

  3. Pfizer CEO Pay Jumps on Turnaround Efforts

    Pfizer Inc (NYSE:PFE) said Chief Executive Ian Read's compensation jumped more than 40 percent last year to $25 million as he steered a steady course for the world's...

  4. Confidence Slumps as CEOs Gear up for Davos

    DAVOS , Switzerland, Jan 24 (Reuters) - Corporate executives are struggling to find paths to growth as the euro zone crisis stokes fears of a return to recession and...

  5. Research cuts may haunt Pfizer, ex-R&D chief says

    By Lewis KrauskopfNEW YORK (Reuters) - Pfizer Inc <PFE.N> may have won over shareholders with its recent decision to pare back research and development spending but ...

  6. Pfizer investors on alert for more shrinkage clues

    By Ransdell PiersonNEW YORK (Reuters) - Pfizer Inc is expected to report slightly lower quarterly earnings on Tuesday, but investors will be more focused on any sign...

  7. Congress Steps Up Probe of White House Health Reform Meetings

    GOP members of the powerful U.S. House Energy and Commerce Committee have stepped up their probe of secret back-room negotiations and quid pro quo deals struck in he...

Freebase CC-BY
Source: Jeff Kindler on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL